| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18487553 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 104 journal articles in the PubMed database | Email to a friend | | |
| Killestein J, Hartung HP
Interferon beta in multiple sclerosis: predicting response at an early stage. [Comment, Journal Article]
J Neurol Neurosurg Psychiatry 2008 Jun; 79(6):616-7.
Full Citation | Publisher Full Text | Find Related Articles | | Durelli L, Barbero P, Bergui M, et al.
MRI activity and neutralizing antibody as predictors of response to IFN-{beta} treatment in MS. [JOURNAL ARTICLE]
J Neurol Neurosurg Psychiatry 2007 Nov 6.
Abstract | Full Citation | Find Related Articles | | Polman C, Schellekens H, Killestein J
Neutralizing antibodies to interferon-beta may persist after cessation of therapy: what impact could they have? [Comment, Editorial]
Mult Scler 2006 Jun; 12(3):245-6.
Full Citation | Publisher Full Text | Find Related Articles | | Deisenhammer F, Giovannoni G
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing/remitting multiple sclerosis. [Comment, Letter]
Mult Scler 2004 Dec; 10(6):713-4; author reply 715.
Full Citation | Publisher Full Text | Find Related Articles | | Rudge P
Interferon antibodies: do they alter the beneficial effects of beta-interferon upon relapse rate in multiple sclerosis? [Comment, Journal Article, Review]
Mult Scler 2004 Apr; 10(2):123-5.
Full Citation | Publisher Full Text | Find Related Articles | | Sørensen S, Koch-Henriksen NJ, Pedersen CR, et al.
[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis] [Journal Article]
Ugeskr Laeger 2004 Oct 4; 166(41):3606-9.
Full Citation | Find Related Articles | | Ciccarelli O, Bagnato F, Mainero C, et al.
Antinuclear antibodies and response to IFNbeta-1a therapy in relapsing-remitting multiple sclerosis. [Journal Article]
Mult Scler 2000 Jun; 6(3):137-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Sorensen PS, Ross C, Clemmesen KM, et al.
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Lancet 2003 Oct 11; 362(9391):1184-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Petersen B, Bendtzen K, Koch-Henriksen N, et al.
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis. [Journal Article]
Mult Scler 2006 Jun; 12(3):247-52.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
